Not logged inDistinct molecular profiles and shared drug vulnerabilities in pancreatic metastases of renal cell carcinoma
Roos-Mattila, Matilda; Kallio, Pauliina; Luck, Tamara J.; Polso, Minttu; Kumari, Romika; Mikkonen, Piia; Valimaki, Katja; Malmstedt, Minna; Ellonen, Pekka; Pellinen, Teijo; Heckman, Caroline A.; Mustonen, Harri; Puolakkainen, Pauli A.; Alitalo, Kari; Kallioniemi, Olli; Mirtti, Tuomas; Rannikko, Antti S.; Pietiainen, Vilja M.; Seppanen, Hanna E. .png)
Share.png)
SaveShare Save Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination statusRoering, Pia; Siddiqui, Arafat; Heuser, Vanina D.; Potdar, Swapnil; Mikkonen, Piia; Oikkonen, Jaana; Li, Yilin; Pikkusaari, Sanna; Wennerberg, Krister; Hynninen, Johanna; Grenman, Seija; Huhtinen, Kaisa; Auranen, Annika; Carpen, Olli; Kaipio, Katja Share Save Share Save ALDH1A1-related stemness in high-grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR-PI3K/aurora kinase inhibitorsKaipio, Katja; Chen, Ping; Roering, Pia; Huhtinen, Kaisa; Mikkonen, Piia; Ostling, Paivi; Lehtinen, Laura; Mansuri, Naziha; Korpela, Taina; Potdar, Swapnil; Hynninen, Johanna; Auranen, Annika; Grenman, Seija; Wennerberg, Krister; Hautaniemi, Sampsa; Carpen, Olli Share Save Clinical implementation of precision systems oncology in the treatment of ovarian cancer based on ex-vivo drug testing and molecular profilingMurumagi, Astrid; Ungureanu, Daniela; Khan, Suleiman; Hirasawa, Akira; Arjama, Mariliina; Valimaki, Katja; Mikkonen, Piia; Niininen, Wilhelmiina; Kumar, Ashwini; Eldfors, Samuli; Pellinen, Teijo; Pietiainen, Vilja; Magi, Andrus; Koivisto-Korander, Riitta; Tapper, Johanna; Loukovaara, Mikko; Aittokallio, Tero; Butzow, Ralf; Kallioniemi, Olli Share Save Discovery and clinical implementation of individualized therapies in acute myeloid leukemia based on ex vivo drug sensitivity testing and multi-omics profilingMalani, Disha; Kumar, Ashwini; Yadav, Bhagwan; Kontro, Mika; Potdar, Swapnil; Bruck, Oscar; Kytola, Sari; Saarela, Jani; Eldfors, Samuli; Ojamies, Poojitha; Riikka, Karjalainen; Majumder, Muntasir Mamun; Vastrik, Imre; Ellonen, Pekka; Kankainen, Matti; Suvela, Minna; Knappila, Siv; Parson, Alun; Palva, Aino; Mattila, Pirkko; Kulesskiy, Evgeny; Turunen, Laura; Laamanen, Karoliina; Lehtinen, Elina; Mikkonen, Piia; Nurmi, Maria; Timonen, Sanna; Murumagi, Astrid; Gjersten, Bjorn Tore; Mustjoki, Satu; Aittokallio, Tero; Wennerberg, Krister; Anders, Simon; Wolf, Maija; Heckman, Caroline; Porkka, Kimmo; Kallioniemi, Olli Share Save Share Save Share Save Precision medicine approach: analysis of renal cancer patient-derived cells with phenomics, genomics and drug sensitivity profilingPietiainen, Vilja M.; Mikkonen, Piia; Saeed, Khalid; Paavolainen, Lassi; Pellinen, Teijo; Potdar, Swapnil; Mpindi, John; Nisen, Harry; Rannikko, Antti; Mirtti, Tuomas; Horvath, Peter; Ostling, Paivi; Kallioniemi, Olli Share Save Share Save Characterization of ascites and tumor-derived ovarian cancer stem-like cells.Kaipio, Katja; Chen, Ping; Huhtinen, Kaisa; Mikkonen, Piia; Ostling, Paivi; Mpindi, John Patrick; Lehtinen, Laura; Roering, Pia; Korpela, Taina; Wennerberg, Krister; Yadav, Bhagwan; Aittokallio, Tero; Kulesskiy, Evgeny; Hynninen, Johanna; Auranen, Annika; Grenman, Seija; Hautaniemi, Sampsa; Carpen, Olli Share Save Novel integrative approach to identify therapy sensitive and insensitive ovarian cancer patients.Chen, Ping; Huhtinen, Kaisa; Kaipio, Katja; Mikkonen, Piia; Aittomaki, Viljami; Lindell, Rony; Hynninen, Johanna; Auranen, Annika; Grenman, Seija; Lehtonen, Rainer; Carpen, Olli; Hautaniemi, Sampsa Share Save Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum-Taxane ChemotherapyChen, Ping; Huhtinen, Kaisa; Kaipio, Katja; Mikkonen, Piia; Aittomaki, Viljami; Lindell, Rony; Hynninen, Johanna; Auranen, Annika; Grenman, Seija; Lehtonen, Rainer; Carpen, Olli; Hautaniemi, Sampsa Share Save High-grade serous ovarian cancer subtyping identifies pathways for targeted therapyHuhtinen, K.; Chen, P.; Mikkonen, P.; Kaipio, K.; Aittomaki, V.; Lindell, R.; Auranen, A.; Lehtonen, R.; Hautaniemi, S.; Carpen, O. Share Save Share Save Characterization of primary high-grade serous ovarian cancer cell lines: Cell line and growth condition specific differences in stem cell marker expression and high-throughput drug screeningRoering, Pia; Mikkonen, Piia; Kaipio, Katja; Huhtinen, Kaisa; Hynninen, Johanna; Auranen, Annika; Kulesskiy, Evgeny; Yadav, Bhagwan; Aittokallio, Tero; Grenman, Seija; Wennerberg, Krister; Carpen, Olli Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}